E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/16/2016 in the Prospect News PIPE Daily.

Lexaria Bioscience raises $93,512 through private placement of units

Company sold units of shares, two-year warrants at $0.06 per unit

By Devika Patel

Knoxville, Tenn., Aug. 16 – Lexaria Bioscience Corp. settled a $93,512 private placement of units on Aug. 11, according to an 8-K filed Tuesday with the Securities and Exchange Commission. The deal priced for $300,000 on July 5.

The company sold 1,558,525 units of one common share and one warrant at $0.06 per unit.

Each warrant is exercisable at $0.14 for two years. The strike price is a 75% premium to $0.08, the July 1 closing share price.

Proceeds will be used for deployment and marketing of hemp-based food products, research and development and general working capital.

Vancouver, B.C.-based Lexaria, formerly Lexaria Corp., is a food sciences company focused on delivering cannabinoid compounds procured from legal, agricultural hemp.

Issuer:Lexaria Bioscience Corp.
Issue:Units of one common share and one warrant
Amount:$93,512
Units:1,558,525
Price:$0.06
Warrants:One warrant per unit
Warrant expiration:Two years
Warrant strike price:$0.14
Pricing date:July 5
Settlement date:Aug. 11
Stock symbol:OTCBB: LXRP
Stock price:$0.08 at close July 1
Market capitalization:$5.12 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.